CTMX CYTOMX THERAPEUTICS INC Delisting Actions 8-K Filing 2025 - Nasdaq Notice On February 24, 2025, CytomX Therapeutics received a notice from Nasdaq stating that its stock price has been below the required minimum of $1.00 for 30 consecutive business days, and it has until August 25, 2025, to regain compliance.Get access to all SEC 8-K filings of the CYTOMX THERAPEUTICS INC